On August 7, 2019, Aprogen pharmaceuticals,Inc. (KOSE:A003060) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,631 KRW | +5.84% | +5.16% | -43.76% |
1st Jan change | Capi. | |
---|---|---|
-43.76% | 78.3M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen pharmaceuticals,Inc. announced that it has received KRW 20.000000214 billion in funding from Aprogen KIC Inc.